Zhang, J., Li, L., Luo, W., Ma, S., & Zhao, Y. (2024). ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis. Clinical and Translational Oncology, 26(12), 2979-2992. https://doi.org/10.1007/s12094-024-03527-z
Chicago Style (17th ed.) CitationZhang, Jingjing, Lingjie Li, Weiwei Luo, Shenglin Ma, and Yanyan Zhao. "ITGB4 Is a Prognostic Biomarker and Correlated with Lung Adenocarcinoma Brain Metastasis." Clinical and Translational Oncology 26, no. 12 (2024): 2979-2992. https://doi.org/10.1007/s12094-024-03527-z.
MLA (9th ed.) CitationZhang, Jingjing, et al. "ITGB4 Is a Prognostic Biomarker and Correlated with Lung Adenocarcinoma Brain Metastasis." Clinical and Translational Oncology, vol. 26, no. 12, 2024, pp. 2979-2992, https://doi.org/10.1007/s12094-024-03527-z.